The anti-lung cancer activity of propylene tethered dihydroartemisinin-isatin hybrids

[1]  Xiaona Lu,et al.  Targeting ion channels for the treatment of lung cancer. , 2021, Biochimica et biophysica acta. Reviews on cancer.

[2]  J. Annema,et al.  Advanced bronchoscopic techniques for the diagnosis and treatment of peripheral lung cancer. , 2021, Lung cancer.

[3]  Tongchao Zhang,et al.  Global burden of lung cancer attributable to ambient fine particulate matter pollution in 204 countries and territories, 1990-2019. , 2021, Environmental research.

[4]  Ping Guo,et al.  The inhibitory effect of dihydroartemisinin on non-small cells lung cancer , 2021, Pharmacological Research - Modern Chinese Medicine.

[5]  Xiao Zhu,et al.  The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  G. Raczak,et al.  Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review , 2020, International journal of molecular sciences.

[7]  B. Mirza,et al.  Artemisinin and its derivatives: a promising cancer therapy , 2020, Molecular Biology Reports.

[8]  C. D. Dela Cruz,et al.  Lung Cancer 2020: Epidemiology, Etiology, and Prevention. , 2020, Clinics in chest medicine.

[9]  Zhen Ding,et al.  Recent advances in isatin hybrids as potential anticancer agents , 2020, Archiv der Pharmazie.

[10]  F. Gao,et al.  Artemisinin-derived hybrids and their anticancer activity. , 2020, European journal of medicinal chemistry.

[11]  Yani Hou,et al.  Isatin–azole hybrids and their anticancer activities , 2020, Archiv der Pharmazie.

[12]  Qi-Pin Qin,et al.  Strong in vitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives. , 2019, European journal of medicinal chemistry.

[13]  Qi-Pin Qin,et al.  High in Vitro and in Vivo Tumor-Selective Novel Ruthenium(II) Complexes with 3-(2'-Benzimidazolyl)-7-fluoro-coumarin. , 2019, ACS medicinal chemistry letters.

[14]  Qi-Pin Qin,et al.  Syntheses, crystal structures and biological evaluation of two new Cu(II) and Co(II) complexes based on (E)-2-(((4H-1,2,4-triazol-4-yl)imino)methyl)-6-methoxyphenol. , 2019, Journal of inorganic biochemistry.

[15]  Qi-Pin Qin,et al.  Synthesis and antitumor mechanisms of two novel platinum(ii) complexes with 3-(2'-benzimidazolyl)-7-methoxycoumarin. , 2018, Metallomics : integrated biometal science.

[16]  P. Singh,et al.  Success stories of natural product-based hybrid molecules for multi-factorial diseases. , 2018, European journal of medicinal chemistry.

[17]  Xin-liang Du,et al.  The pharmacological activities and mechanisms of artemisinin and its derivatives: a systematic review , 2017, Medicinal Chemistry Research.

[18]  Walter J Curran,et al.  Lung cancer: current therapies and new targeted treatments , 2017, The Lancet.

[19]  Shaveta,et al.  Hybrid molecules: The privileged scaffolds for various pharmaceuticals. , 2016, European journal of medicinal chemistry.

[20]  S. Spiro.  Management of lung cancer. , 1990, BMJ.